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Steven N. Emancipator, MD,b Leonard A. R. Golding, MD,a and Kiyotaka Fukamachi, MD, PhDaObjective: The need for pulsatility in the circulation during long-term mechanical
support has been a subject of debate. We compared histologic changes in calf renal
arteries subjected to various degrees of pulsatile circulation in vivo. We addressed
the hypothesis that the local renin–angiotensin system may be implicated in these
histologic changes.
Methods and Results: Sixteen calves were implanted with devices giving differing
degrees of pulsatile circulation: 6 had a continuous flow left ventricular assist device
(LVAD); 6 had a continuous flow right ventricular assist device (RVAD); and 4 had
a pulsatile total artificial heart (TAH). Six other calves were histologic and immuno-
histochemical controls. In the LVAD group, the pulsatility index was significantly
lower (0.28 6 0.07 LVAD vs 0.56 6 0.08 RVAD, vs 0.53 6 0.10 TAH; P ,
0.01), and we observed severe periarteritis in all cases in the LVAD group. The num-
ber of angiotensin II type 1 receptor–positive cells and angiotensin converting
enzyme–positive cells in periarterial areas was significantly higher in the LVAD
group (angiotensin II type 1 receptor: 350 6 139 LVAD vs 8 6 6 RVAD, vs 3 6
2 TAH, vs 3 6 2 control; P , .001; angiotensin-converting enzyme: 325 6 59
LVAD vs 6 6 4 RVAD, vs 6 6 5 TAH, vs 3 6 1 control; P , .001).
Conclusions: The reduced pulsatility produced by a continuous flow LVAD implan-
tation induced severe periarteritis in the kidneys. The local renin–angiotensin system
was up-regulated in the inflammatory cells only in the continuous flow LVAD group.
T
he necessity of maintaining pulsatility in the systemic circulation during long-
term mechanical support has been a subject of debate. Recently, simpler and
smaller continuous flow blood pumps have become more prevalent. The
diminished pulsatility created by support from a continuous flow left ventricular assist
device (LVAD) is physiologically abnormal, and some changes to the structure of the
aortic wall and the renal artery have been reported.1,2 Continuous flow LVAD support
has been reported to cause renal cortical artery hypertrophy and inflammatory cell
infiltration in the renal cortex.2 However, the mechanisms leading to those morpho-
logic changes are still unclear.
In this study, we examined the renal arteries of calves implanted with several dif-
ferent types of circulatory support devices delivering various degrees of systemic
arterial pulsatility. We observed severe inflammatory and morphologic changes in
the kidney only in those calves with continuous flow LVADs. In addition to its pressor
effect, angiotensin II (Ang II), the physiologically active component of the renin–an-
giotensin system (RAS), has a variety of nonhemodynamic actions, including cell
growth, as well as proinflammatory and profibrogenic actions through the Ang II
type 1 receptors (AT1R).3 Many of these actions are associated with cardiovascular
and renal disease.4 Many tissues are thought to be capable of local Ang II production
via the tissue-specific local RAS.5-9 This locally produced Ang II acts on tissue
through resident Ang II receptors. We directed our attention to the local RAS as
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PAbbreviations and Acronyms
ACE 5 angiotensin-converting enzyme
Ang II 5 angiotensin II
AT1R 5 angiotensin II type 1 receptor
eNOS 5 endothelial nitric oxide synthase
LVAD 5 left ventricular assist device
pa 5 periarterial areas
RAS 5 renin–angiotensin system
RVAD 5 right ventricular assist device
TAH 5 total artificial heart
a possible mechanism for those pathologic changes, and we
demonstrated by immunohistochemical analysis that AT1R
and angiotensin-converting enzyme (ACE) were found in in-
flammatory cells that had infiltrated the kidneys of calves
with continuous flow LVADs.
Methods
Animals and Device Description
Twenty-two male Holstein calves (99.86 16.7 kg) were used in this
study. A continuous flow LVAD was implanted in 6 calves, creating
the condition of reduced systemic arterial pulsatile perfusion; a con-
tinuous flow right ventricular assist device (RVAD) was implanted
in 6 calves, representing the condition of pulsatile perfusion and as
a biomaterial control. The RVAD did produce reduced pulsatility in
the pulmonary circulation; however, pulsatility was maintained in
the systemic circulation. A pulsatile total artificial heart (TAH)
was implanted in 4 calves to study pulsatile perfusion. Six normal
calves were used as normal histologic and immunohistochemical
controls. As shown in Table 1, the devices were implanted for var-
ious durations ranging from 22 to 95 days.
Animal Care
This study was approved by the Cleveland Clinic’s Institutional An-
imal Care and Use Committee, and all animals received humane care
in compliance with the ‘‘Guide for the Care and Use of Laboratory
Animals’’ prepared by the Institute of Laboratory Animal Re-
sources, National Research Council, and published by the National
Academy Press, revised 1996.
Implant Procedure
On arrival at the facility, all calves were quarantined for at least 14
days in the Biological Resources Unit. The calves were fasted for 12
hours before surgery. Anesthesia was induced with ketamine, 10
mg/kg intramuscularly, and isoflurane via mask inhalation. Each
animal was then intubated, and anesthesia was maintained with iso-
flurane (1.0%–2.0%) and oxygen.
LVAD Implantation
The CorAide continuous flow left ventricular assist system (Arrow
International, Reading, Pa), originally developed at the Cleveland
Clinic, is a centrifugal continuous flow pump.10 Through a left tho-
racotomy, the outflow graft of the pump was anastomosed to the
descending aorta, and the inflow cannula of the pump was insertedThe Journal of Thointo the left ventricle. An ultrasonic perivascular flow probe (Tran-
sonic Systems Inc, Ithaca, NY) was placed around the outflow graft
for continuous monitoring of the pump output. Arterial pressure was
measured in the carotid artery by a fluid-filled pressure-monitoring
line. After surgery, intravenous nitroprusside was administered to
maintain mean arterial pressure at less than 125 mm Hg and pump
flows at greater than 3.5 L/min.
RVAD Implantation
The Cleveland Clinic’s DexAide blood pump is a centrifugal, con-
tinuous flow blood pump, constructed of the same materials as the
CorAide left ventricular assist system,11 but with a modified design.
Through a left thoracotomy, the outflow graft of the pump was anas-
tomosed to the pulmonary artery, and the inflow cannula of the
pump was inserted into the right ventricle under cardiopulmonary
bypass support. An ultrasonic perivascular flow probe was placed
around the outflow graft. Systemic arterial pressure was measured
in the carotid artery by a fluid-filled pressure-monitoring line. After
cardiopulmonary bypass was discontinued, the RVAD was initiated.
TAH Implantation
The Cleveland Clinic’s MagScrew TAH is an implantable pulsatile
TAH system.12 A right fourth intercostal thoracotomy was per-
formed. Under cardiopulmonary bypass support, the native ventricles
TABLE 1. Characteristics of calves with mechanical
support devices and normal control calves
No. Implant duration (d) Body weight (kg)
LVAD (n 5 6) 1 39 84.0
2 29 93.0
3 31 83.0
4 31 86.0
5 30 92.0
6 95 83.0
Avg. 42.5 6 26.0 86.8 6 4.5
RVAD (n 5 6) 1 30 93.0
2 29 96.0
3 25 160.0
4 22 95.6
5 30 96.9
6 30 113.2
Avg. 27.7 6 3.4 109.1 6 26.0
TAH (n 5 4) 1 83 105.0
2 28 113.0
3 92 110.5
4 67 110.0
Avg. 67.5 6 28.3 109.6 6 3.4
Control (n 5 6) 1 — 100.0
2 — 90.0
3 — 90.0
4 — 110.5
5 — 90.0
6 — 101.0
Avg. — 96.9 6 8.4
LVAD, Left ventricular assist device; RVAD, right ventricular assist device;
TAH, total artificial heart.racic and Cardiovascular Surgery c Volume 136, Number 1 151
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to the main pulmonary artery and the ascending aorta, respectively,
and the inflow cuffs were anastomosed to the left and right atria.
Bioprosthetic valves (Edwards Lifesciences 6900 P series; Edwards
Lifesciences, Inc, Irvine, Calif) were placed into the inflow and out-
flow portions of the TAH. Systemic arterial pressure was measured
in the carotid artery by a fluid-filled pressure-monitoring line. As
cardiopulmonary bypass was discontinued, the TAH was initiated.
Postoperative Hemodynamic Data and Renal
Function
After the operation, the calves were transferred to a long-term care
facility and maintained in cages with continuous hemodynamic
monitoring. An Astro-Med MT95K2 16-channel data acquisition
and recording system (Astro-Med, Inc, West Warwick, RI) contin-
uously recorded arterial pressure, electrocardiogram, and pump
flow. Mean values for arterial pressure, pump flow, and pump speed
were recorded hourly. Systemic arterial pressure pulsatility was
quantified by pulse pressure (systolic pressure2 diastolic pressure)
and pulsatility index (pulse pressure/mean arterial pressure). Renal
function was evaluated weekly by blood urea nitrogen and serum
creatinine analysis.
Autopsy
At the completion of each study, after full heparinization (500 U/kg
bolus injection), the animal was humanely killed with an overdose
of sodium pentobarbital (5000 mg) and potassium chloride (240
mEq), and a thorough autopsy was performed. The renal tissue spec-
imens included medulla and cortex samples from both the right and
left kidneys.
Pathologic Study
All renal tissue specimens were fixed in 10% formaldehyde. Trans-
verse sections 4-mm thick were stained with hematoxylin and eosin
and periodic acid–Schiff for light microscopy evaluation. To quan-
tify morphologic changes, we scanned hematoxylin and eosin–
stained sections at 1003 magnification with a light microscope
equipped with Retiga Exi Fast 1394 camera (Qimaging, Burnaby,
British Columbia, Canada). The arterial wall diameter, wall thick-
ness, wall thickness/wall diameter ratio, wall cross-sectional area,
and ratio of smooth muscle layer cross-sectional area/number of
smooth muscle cells were measured on all arteries in the renal cor-
ticomedullary junction with Image-Pro Plus (Media Cybernetics,
Silver Spring, Md). The average values for each animal were re-
ported as an average of the 20 to 40 arterial cross sections examined.
The wall area was defined as the region between the endothelium
and external elastic lamina. The smooth muscle layer was defined
as the region between the internal and external elastic lamina. The
wall cross-sectional area of the renal arteries was defined as the
mean of the measurements of the two opposite walls in the direction
of the minimal diameter, since that was the direction in which
measurements are least affected by the sectioning angle.13
Immunohistochemical Study
Sections 4-mm thick, cut from paraffin blocks of the renal tiss-
ues, were used. The tissue sections were immunostained by rabbit
anti-AT1R antibody (ab18801; Abcam, Cambridge, United King-
dom), angiotensin-converting enzyme mouse anti-ACE antibody152 The Journal of Thoracic and Cardiovascular Surgery c Jul(MAB3502; Chemicon, Temecula, Calif), and by rabbit polyclonal
to endothelial nitric oxide synthase (eNOS) (ab5589; Abcam). The
tissue sections were deparaffinized in xylene and descending grades
of alcohol. The antigen was retrieved by treating the slides in 10
mmol/L citrate buffer, pH 6.0, in a 120C autoclave for 5 minutes
(for ACE antibody and eNOS) or in 0.025% trypsin and 0.1%
CaCl2 2H2O in 50m MTris buffer, pH 7.6, in a 37
C water bath
for 30 minutes (for AT1R antibody). After the endogenous peroxi-
dase activity had been blocked, the primary and then secondary an-
tibodies were added. Antibody binding was visualized by adding
diaminobenzidine as a chromogen and hematoxylin for counter-
staining. To quantify the number of inflammatory cells present,
we measured AT1R-positive cells and ACE-positive cells on 20 dif-
ferent sections that included the wall of an arcuate artery or interlob-
ular artery at a final magnification of 200:1 by using Image-Pro Plus
Image Plus (Media Cybernetics). The average number of positive
cells per section was reported for each animal.
Statistical Analysis
All data were expressed as mean value6 standard deviation. Statis-
tical analyses were performed with a commercially available soft-
ware program (StatView 5.0; SAS Institute, Inc, Cary, NC).
Differences among groups were assessed by 1-way analysis of var-
iance followed by Bonferroni multiple comparison tests.
Results
Hemodynamic Data and Renal Function
A summary of hemodynamic characteristics obtained during
the course of each experiment is given in Table 2. The pulse
pressures of the LVAD group were significantly smaller than
in the other groups (28.3 6 8.0 mm Hg LVAD, 52.7 6 7.7
mm Hg RVAD, 49.5 6 6.9 TAH; P , .01). In the LVAD
group, the pulsatility index was also significantly lower
than in other groups (0.28 6 0.07 LVAD, 0.56 6 0.08
RVAD, 0.53 6 0.10 TAH; P , .01). The continuous flow
RVAD pump produced reduced pulsatility in the pulmonary
circulation; however, pulsatility was maintained in the sys-
temic circulation. There was no significant difference in the
mean arterial pressures. In the TAH group, the beat rate
was significantly higher (217.8 6 5.9 beats/min TAH,
101.3 6 10.0 beats/min LVAD, 88.6 6 22.7 beats/min
RVAD; P , .001). The pump flow was 6.1 6 1.0 L/min in
the LVAD group, 6.1 6 1.4 L/min in the RVAD group,
and 10.0 6 0.6 L/min in the TAH group.
Pathologic Study
All 6 calves that received a continuous flow LVAD implan-
tation showed periarteritis in the kidneys (Figure 1, A). These
results were not found in the other groups (Figure 1, B to D).
The major pathologic findings were these: The medium-sized
arteries, such as the arcuate and interlobular arteries, showed
wall thickening (Figure 2, A), with abundant mononuclear
cells infiltrating the periarterial areas (Figure 2, B). The
arterial structure was relatively conserved and showed fewer
inflammatory cells in the vascular walls.y 2008
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Compared with the other groups, calves in the continuous
flow LVAD group exhibited significantly greater wall diam-
eter, wall thickness, and wall cross-sectional area (Table 3).
There was no increase in the smooth muscle layer cross-
sectional area/number of smooth muscle cell count ratio in
the LVAD group, suggesting that the increased wall thick-
ness was due to hyperplasia but not hypertrophy.
Immunohistochemical Findings
AT1R was observed in the endothelial and inflammatory
cells that infiltrated the periarterial and cortical interstitial
areas of all animals in the LVAD group (Figure 3, C and
D). ACE was observed in renal tubuli, endothelial cells of
the renal arteries, and inflammatory cells that infiltrated the
periarterial and cortical interstitial areas of all animals in
TABLE 2. Hemodynamics and renal function data
Variables LVAD RVAD TAH
Arterial pressure
(mm Hg)
Systole 116.0 6 9.6 125.8 6 7.1 126.4 6 5.7
Mean 98.5 6 8.0 95.1 6 6.3 97.8 6 5.4
Diastole 89.1 6 7.0 73.3 6 4.4 76.9 6 7.3
Heart rate
(beats/min)
101.3 6 10.0 88.6 6 22.7 217.8 6 5.9*
Pulse pressure
(mm Hg)
28.3 6 8.0y 52.7 6 7.7 49.5 6 6.9
Pulsatility index 0.28 6 0.07y 0.56 6 0.08 0.53 6 0.10
LVAD, Left ventricular assist device; RVAD, right ventricular assist device;
TAH, total artificial heart. *P , .001 vs other groups. yP , 0.01 vs other
groups.the LVAD group (Figure 3, E and F). In other groups,
ACE expression was seen only in the renal tubuli and in
endothelial cells of renal arteries, and there were few ACE-
positive reactions in inflammatory cells.
The average number of inflammatory cells in periarterial
areas (pa) was significantly higher in the LVAD group
(462 6 190 cells/pa LVAD, 31 6 21 cells/pa RVAD,
63 6 36 cells/pa TAH, 13 6 12 cells/pa control; P ,.01;
Figure 4). The average number of AT1R-positive cells in
periarterial areas was significantly higher in the LVAD group
(350 6 139 cells/pa LVAD, 8 6 6 cells/pa RVAD, 3 6
2 cells/pa TAH, 36 2 cells/pa in control; P, .001; Figure 5).
The average number of ACE-positive cells in periarterial
areas was significantly higher in the LVAD group (325 6
59 cells/pa LVAD, 6 6 4 cells/pa RVAD, 6 6 5 cells/pa
TAH, 3 6 1 cells/pa control; P , .001; Figure 6). We
observed a few infiltrated inflammatory cells in the TAH
group; however, we did not observe visible AT1R or ACE
activation in those inflammatory cells.
The immunohistochemical study showed a prominent
expression of eNOS in the endothelium of renal arteries
from the LVAD group (Figure 7, A) that appeared more
prominent than in the other groups (Figure 7, B to D).
Discussion
This study yielded two major findings: (1) Severe periarteritis
in the kidney occurred only in the group implanted with a
continuous flow LVAD and (2) AT1R and ACE were up-
regulated in mononuclear inflammatory cells in the kidneys
of the continuous flow LVAD group. The significant hemody-
namic differences between the LVAD group and the other
groups were lower pulsatility and pulse pressure, but not
mean arterial pressure.Figure 1. Hematoxylin and eosin staining of renal
arteries in the corticomedullary junction area
(magnification 340). A, Calf with continuous flow
left ventricular assist device (LVAD). Extensive hy-
perplasia of the intima, media, and adventitia of the
arteries is evident, alongwithmononuclear inflam-
matory cell infiltrates. B, Calf with continuous flow
right ventricular assist device (RVAD). C, Calf with
pulsatile total artificial heart (TAH). D, Control nor-
mal calf. There are no morphologic changes, sug-
gesting that periarteritis exists in the other
groups (B, C, and D).
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CSPFigure 2. Hematoxylin and eosin staining of kidney
in calf with continuous flow LVAD. A, The cortico-
medullary junction area (magnification 340). The
medium-sized arteries, such as the arcuate artery
and interlobular arteries, showed wall thickening
and thepresenceof inflammatorycells.B, Thearcu-
ate artery: expanded view of area encircled with
yellow line in A (magnification 3100), showing
abundant mononuclear cells accumulating in the
periarterial area. The artery structure is relatively
conserved and has few inflammatory cells in the
vascular wall. There is extensive hyperplasia of
the smoothmuscle layer of themediaof the vessels.
For abbreviations, see Figure 1.Whether or not one needs to maintain pulsatility in the sys-
temic circulation has been a subject of lively discussion. It is
known that flow pulsatility can influence cell signaling. For
example, cyclic shear stress markedly elevates eNOS activity
and is associated with more sustained cytosolic calcium tran-
sients.14,15 Sustained exposure to phasic elevated hydrostatic
pressure stimulates endothelial secretion of an antiprolifera-
tive factor.16 Although numerous research efforts focus on
the influence of mechanical forces on gene expression and
signaling through use of in vitro models of cyclic mechanical
stretching on cultured vascular cells, no reliable nonpulsatile
in vivo models have yet been established. Continuous flow
LVAD support has been reported to cause renal cortical
artery hypertrophy and inflammatory cell infiltration in the
renal cortex.2 However, the mechanisms leading to this
altered structure are still unclear. In this study, we investi-
gated the effects of pulsatility in vivo on the kidney by com-
paring renal histologic findings for differing degrees of
pulsatility produced after the implantation of different types
of circulatory support devices. Our histologic analysis at mul-
tiple levels of the renal artery revealed periarteritis with
smooth muscle layer hyperplasia in the animals implanted
with an LVAD that produced the greatest degree of chronic
reduced systemic arterial pulsatility.
We detected AT1R and ACE in mononuclear cells in the
kidney after exposure to reduced pulsatile circulation. In
recent years, the role of the local RAS has gained consider-
able attention, especially in the heart, brain, eye, testis, andkidney.5-9 Local foci of the RAS generate Ang II, which
acts on resident Ang II receptors. In addition to its pressor
effect, Ang II is a factor in a variety of nonhemodynamic
actions, including proinflammatory, profibrogenic actions
and cell growth through an AT1R, many of which are asso-
ciated with cardiovascular and renal disease.4 For example,
several reports have indicated the possible role of Ang II in
inducing chemoattractants for monocyte/macrophage infil-
tration in a rabbit model of early accelerated arteriosclerosis
and in a rat model of immune complex nephritis.17,18 Ang II
modulates the proliferation of vascular smooth muscle cells
and causes marked thickening of the vascular wall.19-21 We
observed many pathologic changes that can be explained
by Ang II actions: (1) mononuclear cell infiltration into peri-
arterial and interstitial areas and (2) wall thickening and vas-
cular smooth muscle cell hyperplasia in the arcuate and
interlobular arteries. One report stated that shear stress
reduced ACE activity in endothelial cells.22 This result sug-
gests that hemodynamic forces regulate the local RAS. One
possible explanation for the pathologic changes in this study
is that the state of reduced pulsatile circulation may activate
the local RAS and elevate the Ang II level, which in turn
may have induced an inflammatory reaction and vascular
proliferation in the kidney.
In this study, the outflow graft of the LVAD was anasto-
mosed to the descending thoracic aorta, whereas the majority
of LVADs are likely to be anastomosed to the ascending aorta
during a clinical implantation. Our healthy calf heart modelTABLE 3. Morphometric data
LVAD RVAD TAH Control
Wall diameter (mm) 310.8 6 56.8y 242.5 6 36.5 225.7 6 18.1 194.2 6 15.6
Wall thickness (mm) 121.9 6 27.1* 88.7 6 15.0 75.1 6 14.0 63.3 6 7.0
Wall thickness/diameter 0.38 6 0.01 0.35 6 0.01 0.32 6 00.3 0.34 6 0.03
Wall CSA (mm2) 13.6 6 5.1y 9.1 6 3.1 6.5 6 1.7 4.8 6 0.5
SML CSA/nSMC (mm/cell) 477 6 220 435 6 107 615 6 497 330 6 75
LVAD, Left ventricular assist device; RVAD, right ventricular assist device; TAH, total artificial heart; CSA, cross-sectional area; SML, smooth muscle layer;
nSMC, number of smooth muscle cells. *P , .01 vs other groups; yP , .05 vs other groups.
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PFigure 3. Histopathology and immunohisto-
chemistry of serial sections of renal arteries
from a calf with a continuous flow LVAD (magni-
fication 3200). Hematoxylin and eosin staining
of the interlobular artery (A) and cortical intersti-
tial area (B). Immunohistochemical staining for
angiotensin II type 1 receptor (AT1R) (C and D)
and angiotensin-converting enzyme (ACE) (E
and F). AT1R is observed in the endothelial cells
and inflammatory cells that infiltrated the periar-
terial area (C) and cortical interstitial area (D).
ACE is observed in renal tubuli, endothelial
cells, the smooth muscle layer, and in inflamma-
tory cells that had infiltrated the periarterial
area (E) and cortical interstitial area (F). For
abbreviations, see Figure 1.with a descending aorta anastomosis is a study limitation.
One group reported that at moderate levels of continuous
flow LVAD support (25% to 40% of cardiac output), the
amount of blood flow distal to the outflow graft anastomosis
decreased approximately 25% owing to increased regurgitant
blood flow in the aorta.23 We considered the possibility of
systemic RAS activation after LVAD implantation as a result
of decreased renal perfusion and ischemic changes in the kid-
ney. However, the pathologic diagnosis and the histologic
changes in the kidney included mainly periarteritis and not is-
chemic changes. The systemic RAS is an endocrine system
responsible for correcting acute hypotension through changes
in peripheral vascular resistance and electrolyte homeosta-
sis.24,25 Renin release is mainly regulated by reduced renal
blood pressure; renal blood flow plays only a minor role in
renin release.26 We believe that our findings of AT1R and
ACE up-regulation in the periarterial and cortical interstitial
inflammatory cells and the fact that there was no difference
in the mean arterial pressure between the groups further sup-
ports the hypothesis that the local RAS might play a major
role in these histologic changes. However, more focused
experiments will be needed to evaluate the relative contribu-The Journal of Thotion of systemic and local RAS factors, including measure-
ments of serum RAS levels and renal arterial flow and
pressure after continuous flow LVAD implantations.
There are some reports on the positive effects of pulsatility
on the eNOS gene expression in cultured endothelial cells and
isolated blood vessels.14,27,28 Nakano and associates29
showed that increased release of nitric oxide and the activa-
tion of eNOS resulted after pulsatile pump implantation in
their short-term studies. However, our immunohistochemical
study showed a prominent expression of eNOS in the endo-
thelium of renal arteries after long-term continuous flow
LVAD implantation. Recent in vivo studies have shown
that Ang II stimulates an increase in eNOS messenger RNA
and nitric oxide production. The prominent expression of
eNOS in the renal artery endothelium of this study could be
explained by intervention of the local RAS.30
Implanted mechanical circulatory support systems have
an inherent potential to cause systemic inflammatory
responses. Ankersmit, and associate31 reported that transient
immunologic activation was observed in patients receiving
a continuous flow LVAD. The authors suspected that the
presence of inflammatory cells may indicate immunologicracic and Cardiovascular Surgery c Volume 136, Number 1 155
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study were both centrifugal continuous flow pumps of the
same volume and weight and were manufactured from the
same material, both pumps can be regarded as the same an-
tigen for the animals in this study. However, only those an-
imals implanted with an LVAD showed inflammatory
changes. On the basis of this result, we believe that an im-
munologic reaction to the LVAD blood pump was not
primarily responsible for the histologic changes observed
in the kidneys.
Figure 4. The number of inflammatory cells in periarterial areas
from the continuous flow LVAD group was significantly higher
than in the other groups. yP< .01. For abbreviations, see Figure 1.
Figure 5. The number of AT1R-positive cells in periarterial areas
from the continuous flow LVAD group was significantly higher
than in the other groups. *P< .001. For abbreviations, see Figure 1.156 The Journal of Thoracic and Cardiovascular Surgery c JulyThe positive effects of treatment with ACE inhibitors or
angiotensin receptor blockers for patients with heart failure
have been reported.32-34 Most patients who receive a contin-
uous flow LVAD take these medications as part of a standard
therapeutic regimen to suppress the progression of heart fail-
ure, and there is a possibility that these therapies incidentally
prevent inflammatory changes such as periarteritis in the kid-
ney. Further research will be needed to determine the effects
of ACE inhibitors or angiotensin receptor blockers on the
mechanisms of these pathologic changes.
As mentioned earlier, a limitation to this study is the fact
that we did not measure the systemic RAS level and that the
systemic arterial pressure was measured by a fluid-filled
pressure-monitoring line in the carotid artery. Assessment
of the histologic changes in the kidney would best be evalu-
ated by a direct comparison of renal arterial pressure and flow
measurements. Also, the immunohistochemical analyses
have the possibility of nonspecific binding. A second method
to confirm activation of the local RAS would strengthen this
analysis. Six normal calves were used as normal histologic
and immunohistochemical controls; however, we did not
record hemodynamic control data from them. Incorporation
of these changes into in vivo protocols is intended for further
prospective studies.
In conclusion, only the continuous flow LVAD group
demonstrated renal periarteritis, up-regulation of the local
RAS in inflammatory cells, and reduced systemic arterial
pressure pulsatility. The study design ruled out a systemic
inflammatory response resulting from the blood pump bio-
materials and supports the hypothesis that activity of the local
RAS secondary to decreased renal arterial pressure pulsatility
is the primary factor leading to these pathologic findings.
Figure 6. The number of ACE-positive cells in periarterial areas
from the continuous flow LVAD group was significantly higher
than in the other groups. *P< .001. For abbreviations, see Figure 1.2008
Ootaki et al Cardiopulmonary Support and PhysiologyFigure 7. Immunohistochemical staining for en-
dothelial nitric oxide synthase (eNOS) (magnifi-
cation 3200). A, Calf with continuous flow
LVAD. The immunohistochemical study showed
a prominent expression of eNOS in the endothe-
lium of renal arteries that appeared more promi-
nent in LVAD group than other group. B, Calf
with continuous flow RVAD. C, Calf with pulsa-
tile-TAH. D, Control normal calf. For abbreviations,
see Figure 1.CS
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